e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Allarity Therapeutics, Inc. - Common stock (NQ:ALLR)

1.105 +0.025 (+2.31%)

Streaming Delayed Price Updated: 10:20 AM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Allarity Therapeutics, Inc. - Common stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

May 30, 2023

Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 30, 2023

Via Benzinga

Why Seelos Therapeutics Shares Are Trading Lower By 10%; Here Are 20 Stocks Moving Premarket ↗

May 30, 2023

Gainers QualTek Services Inc. (NASDAQ: QTEK) shares rose 206.7% to $0.2350 in pre-market trading after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter...

Via Benzinga

First Prospective Clinical Validation of Allarity's DRP® Companion Diagnostic to be Presented at 2023 ASCO Annual Meeting

May 30, 2023

From Allarity Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

May 29, 2023

Via Benzinga

Allarity Therapeutics Accelerates Trial Enrollment To Bring FDA-Approved Breast Cancer Treatment To European Market - Interim Results Could Be Released In Second Half Of 2023

April 27, 2023

Via ACCESSWIRE

Allarity Therapeutics Accelerates Trial Enrollment To Bring FDA-Approved Breast Cancer Treatment To European Market – Interim Results Could Be Released In Second Half Of 2023 ↗

April 26, 2023

Recently, Allarity Therapeutics, Inc. (NASDAQ: ALLR) announced plans to speed up its Phase 2 clinical trial for IXEMPRA®, the clini

Via Benzinga

Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

April 21, 2023

Gainers Mangoceuticals, Inc. (NASDAQ: MGRX) shares jumped 207% to $2.84. The company announced Thursday, that it's featured on Webull Corporate Communications Service Platform.

Via Benzinga

Nasdaq Edges Higher; Abbott Laboratories Reports Upbeat Results ↗

April 19, 2023

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Wednesday. The Dow traded down 0.23% to 33,899.20 while the NASDAQ rose 0.16% to 12,172.92. The S&P 500,...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 19, 2023

Via Benzinga

Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

April 19, 2023

Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering.

Via Benzinga

Virax Biolabs (VRAX) Stock Soars on PCR Test DIstribution Agreement ↗

April 19, 2023

Virax Biolabs (VRAX) stock is on the rise Wednesday after the company secured a Marburg Virus Real Time PCR Kit distribution deal.

Via InvestorPlace

LUNR Stock Alert: The $719 Million Reason Intuitive Machines Is Rising Today ↗

April 19, 2023

Intuitive Machines (LUNR) stock is heading higher on Wednesday thanks to news of a $719 million, five-year award from NASA.

Via InvestorPlace

Allarity Therapeutics, Inc. Announces Pricing of $7.5 Million Public Offering

April 19, 2023

From Allarity Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 19, 2023

Via Benzinga

Why Is Gamida Cell (GMDA) Stock Down 19% Today? ↗

April 19, 2023

Gamida Cell (GMDA) stock is falling on Wednesday after the cell therapy company revealed details of a public securities offering.

Via InvestorPlace

Why Is Allarity Therapeutics (ALLR) Stock Down 22% Today? ↗

April 19, 2023

Allarity Therapeutics (ALLR) stock is falling hard on Wednesday after the clinical-stage pharmaceutical company launched a public offering.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

April 19, 2023

It's time for another dive into the biggest pre-market stock movers traders will want to know about on Wednesday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 18, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 18, 2023

Via Benzinga

Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 18, 2023

Gainers Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 17, 2023

Via Benzinga

This Combination Therapy Could Help Change Cancer Treatment - Take A Deeper Look Into Allarity Therapeutics' Trial

April 17, 2023

Via ACCESSWIRE

Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 17, 2023

Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82.

Via Benzinga

7 Sorry Pharma Stocks to Sell in April Before It’s Too Late ↗

April 16, 2023

You have to be patient when investing in pharma stocks. But sometimes the risk and the wait aren't worth the rewards.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 14, 2023

Via Benzinga

This Combination Therapy Could Help Change Cancer Treatment — Benzinga Looks Deeper Into Allarity Therapeutics' Trial, Including An Interview With An Oncology Expert ↗

April 13, 2023

Allarity Therapeutics (NASDAQ: ALLR) dosed its first patient in Phase 1b of its clinical trial for the novel combination therapy of two drug

Via Benzinga

Abstract Evaluating Allarity’s DRP® Companion Diagnostic for Cisplatin Accepted at 2023 ASCO Annual Meeting

April 11, 2023

From Allarity Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

April 07, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 05, 2023

Via Benzinga

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy